FDA Inspection
MP Biomedicals Asia Pacific Pte LtdMP Biomedicals Asia Pacific Pte Ltd – FDA Inspection, Mar 21, 2025
Record Details
This FDA Inspection record concerns MP Biomedicals Asia Pacific Pte Ltd, with an inspection on March 21, 2025, issued by the Office of Inspections and Investigations, covering biologics.
View Company Profile
ID · d5bda2f5-0d87-4694-ab4d-3f50a76794bf
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1265006
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
2- 21 CFR 820.50(b)Approval, inadequate purchasing data
- 21 CFR 820.70(c)Environmental control Lack of or inadequate procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of MP Biomedicals Asia Pacific Pte Ltd
3| Date | Classification | Office | Project area |
|---|---|---|---|
| December 14, 2018 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 13, 2017 | Not classified | Office of Inspections and Investigations | |
| November 7, 2016 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for MP Biomedicals Asia Pacific Pte Ltd
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.